Navigation Links
Treatment Corrects Severe Insulin Imbalance in Animal Studies
Date:7/31/2008

--Could Become First Effective Drug for Rare Genetic Disorder in Children--

PHILADELPHIA, July 31 /PRNewswire-USNewswire/ -- Researchers have used a drug to achieve normal levels of blood sugar in animals genetically engineered to have abnormally high insulin levels. If this approach succeeds in humans, it could become an innovative medicine for children with congenital hyperinsulinism, a rare but potentially devastating genetic disease in which insulin levels become dangerously high.

"There is currently no effective medical treatment for children with the most common type of congenital hyperinsulinism," said study leader Diva D. De Leon, M.D., a pediatric endocrinologist at The Children's Hospital of Philadelphia. "This type of congenital hyperinsulinism is caused by mutations in genes that encode important potassium channels in the pancreatic beta cells." The study team, from Children's Hospital and the University of Pennsylvania School of Medicine, published their report online on July 17 in the Journal of Biological Chemistry.

In congenital hyperinsulinism (HI), genetic mutations damage the insulin-secreting beta cells in the pancreas. Insulin levels rage out of control and severely reduce blood glucose, a condition called hypoglycemia. If untreated, hypoglycemia may cause irreversible brain damage or death in children. Congenital HI occurs in an estimated one in 50,000 U.S. children, with a somewhat higher incidence among certain groups, such as Ashkenazic Jews.

For the past 20 years, the standard medical treatment for some forms of HI has been the drug diazoxide, which controls insulin secretion by opening up crucial potassium channels in beta cells. However, this drug does not work in the most common and severe forms of HI, in which mutations prevent those channels from forming.

When the abnormal beta cells are confined to a discrete portion of the pancreas, as occurs in approximately half of HI cases, precise surge
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Reveals Novel LCD Solution Provides Significant Benefits Versus Calcipotriol In Treatment Of Moderate Psoriasis
2. First Ever Study on Alzheimers Disease Treatment in Hispanics Presented at Major Medical Meeting
3. Four Alzheimers Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation
4. Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
5. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
6. Two New Alzheimers Disease Studies Show Advances Against Different Treatment Targets
7. Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL
8. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
9. MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis
10. InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
11. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...D LASERS just announced that industry leading dent... position of Medical Director. In his new role, D...ch and development of new soft and hard tissue den...g education credits, authoring articles for relate...ng and seminar engagements. ,, "We are very for...
(Date:11/9/2009)...swire/ -- Unwavering from its pursuit of producing...,s economic climate, Lutronic, Inc., a leading dev...troduces the MOSAIC CO2, a full-featured fractiona...OSAIC CO2 offers many of the features unique to Lu...and stamping operation modes and patented Controll...
(Date:11/9/2009)...all/ -- Arcadia Resources, Inc. (NYSE Amex: KAD )... care services under the Arcadia HealthCare(SM) br...of Directors. Goldsmith will replace Tres Lund wh..., (Photo: http://www.newscom.com/cgi-bin/prnh/2...Paul Professor of Government and Director of Innov...
Breaking Medicine Technology:AMD LASERS Names Dr. James Jesse as Medical Director 2Lutronic(R) Unleashes the New MOSAIC CO2 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 3PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 1PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 2PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 3PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 4PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 5PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 6Lithium Ion Battery Maker Names New President 13967 1Lithium Ion Battery Maker Names New President 13967 2Lithium Ion Battery Maker Names New President 13967 3Lithium Ion Battery Maker Names New President 13967 4Lithium Ion Battery Maker Names New President 13967 5Lithium Ion Battery Maker Names New President 13967 6Pandemic flu can infect cells deep in the lungs says new research 9859 1Pandemic flu can infect cells deep in the lungs says new research 9859 2Pandemic flu can infect cells deep in the lungs says new research 9859 3
...etion of Phase III Trials of Light Infusion Therap...ectal Cancer and Phase I/II and Phase II... Wash., July 15 Light Sciences Oncology, Inc.,(LS...sion Therapy(TM),(Litx(TM)) to treat cancer and ot... $40.1 million in a Series C round of financing. T...
...is of the Alzheimer,s Disease Market Now Available...WALTHAM, Mass., July 15 Decision Resources, one o...for pharmaceutical and,healthcare issues, finds th...continue the development of Flurizan, the most lik...disease treatment becomes Elan/Wyeth,s,bapineuzuma...
Other Medicine Technology:Light Sciences Oncology Raises $40.1 Million in Series C Financing 2Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimer's Drug After Flurizan's Discontinuation 2
(Date:11/9/2009)... Rabbits implanted with new cells regained sexual...v. 9 (HealthDay News) -- Researchers were able to ...nises by growing new penile tissue in the lab and ...human application is a ways off, researchers say t... erectile dysfunction in men. , "We were able t...
(Date:11/9/2009)... , Tomorrow may be too la...etes condition, according to TOPS Club, Inc. (Take...upport organization. , (V... when it comes to preventing or improving a diabet...ff Pounds Sensibly), the nonprofit weight-loss sup...
(Date:11/9/2009)... , SANTA MONICA, Calif., Nov. 9 /PRNewswire/ ... Foundation joined philosophy on Saturday to...nce support services throughout California by buil... shelters. Enough kits were created to give one t...served in one of Los Angeles County,s domestic vio...
(Date:11/9/2009)... , DETROIT, Nov. 9 ...armanos Cancer Center has been selected the most p...higan, according to a survey by the National Resea...m.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) ,, ...uestionnaire between September 2008 and August 200...
(Date:11/9/2009)... , NEW YORK, Nov. 9 /PRNewswire/ -- Phoen...l and drug abuse treatment and prevention program,...h.D., a nationally and internationally recognized ...as Chief Clinical Officer, effective January 1, 20...ont of substance abuse treatment research and her ...
Breaking Medicine News(10 mins):Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3
...ients with clinically operable cervical cancer fro...retreatment imaging does not lead to increased sur...developed a decision-analytic model to determine t... Boston, and lead author of the study. What we fou...
... Stem Cell Network Annual Science Meeting in Edinb...isms normally involved in balancing different func... Her team from Barts and the London School of Med...gnant brain tumours. This work has been funded by...
...ood cell production is controlled could lead to im...anaemia, according to West Australian medical rese...s published in Blood, the journal of the American ...Research (WAIMR) Director Peter Klinken and his La...
...ry on how immune system responds to invaders , ...e system T-cells don,t begin to multiply until up ...ng that changes current thinking about how the imm...an evolutionary safeguard against the risk of an a...
...centric Medical,Inc., the global leader in devices...ay announced that Maria Sainz has been named Presi...he new appointment was effective,April 8, 2008., ... Cardiac Surgery division of Guidant Corporation a...
...ify Systems, Inc., a,real-time compression technol...amplify for Windows Release 2.6 and Samplify for W...vides the same compression and,decompression engin..., "Many of our customers in the defense and medic...
Other Medicine News:Health News:Stem cells and cancer: Scientists investigate a fine balancing act 2Health News:Twin findings raise hopes of improved anemia treatments 2Health News:T-Cell Duplication Delayed Up to 3 Days After Infection 2Health News:Maria Sainz Named President and CEO of Concentric Medical 2Health News:Samplify Systems Announces Availability of Samplify for Windows Release 2.6, and Samplify for Windows Embedded Edition, Transforming RF Data Recording Applications with X-COM Systems 2Health News:Samplify Systems Announces Availability of Samplify for Windows Release 2.6, and Samplify for Windows Embedded Edition, Transforming RF Data Recording Applications with X-COM Systems 3
...program offers state-of-the-art quality in an inst... strength and durability. Low profile cutting tips...Series I instruments are available in just about e...r large and small joint arthroscopic procedures.,...
...program offers state-of-the-art quality in an inst... strength and durability. Low profile cutting tips...Series I instruments are available in just about e...r large and small joint arthroscopic procedures.,...
...es facilitates fast and effective resection of men...y shaped meniscal rim. The flat, crescent-shaped t... tightest joint spaces. Made in the U.S. at Arthre...ence in arthroscopy hand instrument design guarant...
...es facilitates fast and effective resection of men...y shaped meniscal rim. The flat, crescent-shaped t... tightest joint spaces. Made in the U.S. at Arthre...ence in arthroscopy hand instrument design guarant...
Medicine Products: